Quantum-Si (NASDAQ:QSI) Shares Down 2.7% – Time to Sell?

Quantum-Si Incorporated (NASDAQ:QSI) shares were down 2.7% on Friday . The company traded as low as $0.9332 and last traded at $0.9467. Approximately 3,303,668 shares changed hands during mid-day trading, a decline of 48% from the average daily volume of 6,382,231 shares. The stock had previously closed at $0.9730.

Analyst Ratings Changes

A number of equities research analysts have weighed in on QSI shares. Weiss Ratings restated a “sell (d-)” rating on shares of Quantum-Si in a research report on Friday, March 27th. Canaccord Genuity Group cut their target price on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, March 4th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $1.00.

Quantum-Si Stock Down 2.7%

The stock has a market capitalization of $206.15 million, a price-to-earnings ratio of -1.86 and a beta of 3.18. The business has a 50-day simple moving average of $0.96 and a two-hundred day simple moving average of $1.06.

Quantum-Si (NASDAQ:QSI) last released its earnings results on Thursday, May 7th. The company reported ($0.10) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02. The firm had revenue of $0.26 million during the quarter, compared to the consensus estimate of $0.30 million. Quantum-Si had a negative return on equity of 47.35% and a negative net margin of 5,605.88%. On average, analysts forecast that Quantum-Si Incorporated will post -0.49 EPS for the current year.

Insider Buying and Selling

In related news, CFO Jeffry R. Keyes sold 37,381 shares of the firm’s stock in a transaction that occurred on Tuesday, April 21st. The shares were sold at an average price of $0.99, for a total transaction of $37,007.19. Following the completion of the sale, the chief financial officer directly owned 1,732,582 shares in the company, valued at approximately $1,715,256.18. This trade represents a 2.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Jeffrey Alan Hawkins sold 83,712 shares of the firm’s stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $1.01, for a total transaction of $84,549.12. Following the sale, the chief executive officer owned 3,776,135 shares of the company’s stock, valued at $3,813,896.35. The trade was a 2.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 212,904 shares of company stock valued at $205,021 over the last 90 days. 22.04% of the stock is currently owned by insiders.

Institutional Trading of Quantum-Si

A number of large investors have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. boosted its holdings in Quantum-Si by 15.6% during the second quarter. JPMorgan Chase & Co. now owns 66,656 shares of the company’s stock worth $131,000 after buying an additional 9,005 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in Quantum-Si by 27.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 49,082 shares of the company’s stock worth $96,000 after purchasing an additional 10,564 shares during the period. Prudential Financial Inc. acquired a new position in Quantum-Si in the 2nd quarter worth approximately $25,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Quantum-Si by 23.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 70,552 shares of the company’s stock worth $85,000 after purchasing an additional 13,546 shares during the period. Finally, Cerity Partners LLC acquired a new position in Quantum-Si in the 2nd quarter worth approximately $29,000. 39.90% of the stock is currently owned by institutional investors.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.